Sigmoidoscopy Has Sustained Effect on CRC Incidence, Mortality
Pooled analysis of four large-scale trials demonstrated sustained effect on CRC incidence and mortality for 15 years
Diagnosis & Disease Information
FDA Clears SKOUT to Detect Colorectal Polyps in Real Time During Colonoscopy
SKOUT is designed to recognize suspicious tissue and provide real-time feedback to gastroenterologists.
CRC Screening Recommended for Average-Risk Adults Age 50 to 75
CRC screening test should be selected based on discussion of benefits, harms, costs with patients
Fluorouracil Injection Recalled Due to Glass Particulate
Fresenius Kabi USA, LLC is voluntarily recalling 2 lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, due to the potential for glass particulate. The recalled products, distributed between December 6, 2018 and February 20, 2019, have the following NDC number, lot number, and expiration date: 63323-117-69, 6120341, 4/2020 63323-117-61, 6120420, 4/2020…
Number of Colorectal CA Deaths Projected to Rise Worldwide
An overall rise in the number of colorectal cancer deaths worldwide is expected through 2035, according to a study recently published in the International Journal of Cancer.
ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer
The median overall survival was 18.4 and 13.9 months in the sunitinib-alone and nephrectomy-sunitinib groups, respectively. There were no significant between-group differences in response rate or progression-free survival.
Hepatocellular Carcinoma Rate with Long-Term Entecavir/Tenofovir Tx
Older age, lower platelets at baseline and year five, liver stiffness 12 kPa linked to HCC development
Genetics Should Play a Bigger Role in Clinical Decision-Making
As home genetic testing grows, patients will be bringing their results to physicians for reaction and response. Physicians will need to be proactively prepared.
Nut Consumption Linked to Survival in Colon Cancer Patients
The researchers found that patients who adhered closely to the guidelines regarding exercise, diet, and excess weight had a 42% lower mortality risk than those who didn’t.
FDA Gives Green Light to Stivarga HCC Indication
A trial involving 573 patients with HCC whose tumors progressed after receiving sorafenib demonstrated the safety and efficacy of Stivarga in this population.
